The DOI matches its Crossref record, with a small difference in title or year; 32 of the 32 references it cites were found in a registry or an index.
Reactive Oxygen Species from Mitochondria Induce Cyclooxygenase-2 Gene Expression in Human Mesangial Cells
Open accessAbstract
Hyperglycemia increases the production of reactive oxygen species (ROS) from the mitochondrial electron transport chain in bovine endothelial cells. Because several studies have postulated a role for prostaglandins (PGs) in the glomerular hyperfiltration seen in early diabetes, we evaluated the effect of mitochondrial ROS on expression of the inducible isoform of cyclooxygenase (COX-2) in cultured human mesangial cells (HMCs). We first confirmed that incubation of HMC with 30 mmol/l glucose significantly increased COX-2 mRNA but not COX-1 mRNA, compared with 5.6 mmol/l glucose. Similarly, incubation of HMCs with 30 mmol/l glucose significantly increased mitochondrial membrane potential, intracellular ROS production, COX-2 protein expression, and PGE2 synthesis, and these events were completely suppressed by thenoyltrifluoroacetone or carbonyl cyanide m-chlorophenylhydrazone, inhibitors of mitochondrial metabolism, or by overexpression of uncoupling protein-1 or manganese superoxide dismutase. Furthermore, increased expression of COX-2 mRNA and protein was confirmed in glomeruli of streptozotocin-induced diabetic mice. In addition, hyperglycemia induced activation of the COX-2 gene promoter, which was completely abrogated by mutation of two nuclear factor κB (NF-κB) binding sites in the promoter region. Our results suggest that hyperglycemia increases mitochondrial ROS production, resulting in NF-κB activation, COX-2 mRNA induction, COX-2 protein production, and PGE2 synthesis. This chain of events might contribute to the pathogenesis of diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nox2-derived ROS [185] and matrix mtROS [186] were suggested to induce COX. However, this suggestion was based exclusively on data obtained with diphenyl iodinium (DPI), a general flavoprotein inhibitor with various side effects and with lack of specificity (see Section 7). Therefore, the findings are not fully conclusive.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [186]
In the citing paper
“This was suppressed by reduction in membrane potential by chemical inhibition or by UCP1 overexpression, but, curiously, also suppressed by MnSOD, which should actually increase H2O2 production from superoxide.”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [165]
In the citing paper
“High glucose also reportedly increased H2O2 production by dichlorodihydrofluorescein fluorescence in human mesangial cells (165).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [165]
In the citing paper
“This was suppressed by reduction in membrane potential by chemical inhibition or by UCP1 overexpression, but, curiously, also suppressed by MnSOD, which should actually increase H2O2 production from superoxide.”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [165]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Self-citationRole of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. (1991) · Diabetes · doi:10.2337/diab.40.4.405 · Cited by 3,791
Wang, H., & Joseph, J. A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00107-0 · Cited by 2,355
(2000) · PubMed · Cited by 2,095
Oxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,921
Du, X.-L., Edelstein, D., Rossetti, L., Fantus, I. G., Goldberg, H. J., Ziyadeh, F. N., Wu, J., & Brownlee, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.12222 · Cited by 1,152
Self-citationExtension of Life-Span with Superoxide Dismutase/Catalase Mimetics
Melov, S., Ravenscroft, J., Malik, S., Gill, M. S., Walker, D. W., Clayton, P., Wallace, D. C., Malfroy, B., Doctrow, S. R., & Lithgow, G. J. (2000) · Science · doi:10.1126/science.289.5484.1567 · Cited by 913
Harris, R. C., McKanna, J. A., Akai, Y., Jacobson, H. R., DuBois, R. N., & Breyer, M. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117620 · Cited by 856
Role of oxidative stress in development of complications in diabetes
Baynes, J. W. (1991) · Diabetes · doi:10.2337/diabetes.40.4.405 · Cited by 810
Cited by
Sorted by citations
Yu, T., Robotham, J. L., & Yoon, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511154103 · Cited by 1,246
Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
Forbes, J. M., Coughlan, M. T., & Cooper, M. E. (2008) · Diabetes · doi:10.2337/db08-0057 · Cited by 1,203
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina
SanGiovanni, J. P., & Chew, E. Y. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.06.002 · Cited by 905
A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
Kanwar, Y. S., Sun, L., Xie, P., Liu, F.-Y., & Chen, S. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092150 · Cited by 780
Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links.
Oguntibeju, O. O. (2019) · Europe PMC (PubMed Central) · Cited by 758
Sivitz, W. I., & Yorek, M. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2531 · Cited by 742
Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications
Rovira-Llopis, S., Bañuls, C., Diaz-Morales, N., Hernandez-Mijares, A., Rocha, M., & Victor, V. M. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.013 · Cited by 657
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633
The pathogenesis of diabetic nephropathy
Dronavalli, S., Duka, I., & Bakris, G. L. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0894 · Cited by 627
Diabetic Nephropathy: Mechanisms of Renal Disease Progression
Kanwar, Y. S., Wada, J., Sun, L., Xie, P., Wallner, E. I., Chen, S., Chugh, S. S., & Danesh, F. R. (2008) · Experimental Biology and Medicine · doi:10.3181/0705-mr-134 · Cited by 597
Ferulic acid: Pharmacological and toxicological aspects
Mancuso, C., & Santangelo, R. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.12.024 · Cited by 572
Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species
Bashan, N., Kovsan, J., Kachko, I., Ovadia, H., & Rudich, A. (2009) · Physiological Reviews · doi:10.1152/physrev.00014.2008 · Cited by 542
The Role of Oxidative Stress in Diabetic Complications
Niedowicz, D. M., & Daleke, D. L. (2005) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:43:2:289 · Cited by 533
Kukidome, D., Nishikawa, T., Sonoda, K., Imoto, K., Fujisawa, K., Yano, M., Motoshima, H., Taguchi, T., Matsumura, T., & Araki, E. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0943 · Cited by 504
Self-citationEndothelium structure and function in kidney health and disease
Jourde‐Chiche, N., Fakhouri, F., Dou, L., Bellien, J., Burtey, S., Frimat, M., Jarrot, P., Kaplanski, G., Quintrec, M. L., Pernin, V., et al. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0098-z · Cited by 516
Nox4 NAD(P)H Oxidase Mediates Hypertrophy and Fibronectin Expression in the Diabetic Kidney
Gorin, Y. C., Block, K. L., Hernandez, J., Bhandari, B., Wagner, B., Barnes, J. L., & Abboud, H. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502412200 · Cited by 496
Wang, W., Wang, Y., Long, J., Wang, J., Haudek, S. B., Overbeek, P., Chang, B. H. J., Schumacker, P. T., & Danesh, F. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.009 · Cited by 476
Subcellular localization of Nox4 and regulation in diabetes
Block, K. L., Gorin, Y. C., & Abboud, H. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906805106 · Cited by 484
The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy
Jiang, T., Huang, Z., Lin, Y., Zhang, Z., Fang, D., & Zhang, D. D. (2010) · Diabetes · doi:10.2337/db09-1342 · Cited by 440
Nishikawa, T., & Araki, E. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.1458 · Cited by 391
Self-citationChemistry and Antihypertensive Effects of Tempol and Other Nitroxides
Wilcox, C. S., & Pearlman, A. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000240 · Cited by 376
Oxidative stress in early diabetic nephropathy: fueling the fire
Singh, D. K., Winocour, P. H., & Farrington, K. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.212 · Cited by 353
Jha, J. C., Gray, S. P., Barit, D., Okabe, J., El-Osta, A., Namikoshi, T., Thallas-Bonke, V., Wingler, K., Szyndralewiez, C., Heitz, F., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070810 · Cited by 352
Kitada, M., Kume, S., Imaizumi, N., & Koya, D. (2011) · Diabetes · doi:10.2337/db10-0386 · Cited by 345
Du, Y., Veenstra, A. A., Palczewski, K., & Kern, T. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314575110 · Cited by 343
Piconi, L., Quagliaro, L., Assaloni, R., ROS, R. D., Maier, A., Zuodar, G., & Ceriello, A. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.613 · Cited by 332
Ferulic acid and its therapeutic potential as a hormetin for age-related diseases
Barone, E., Calabrese, V., & Mancuso, C. (2008) · Biogerontology · doi:10.1007/s10522-008-9160-8 · Cited by 296
Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury
Fakhruddin, S., Alanazi, W. A., & Jackson, K. E. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8379327 · Cited by 300
Diabetic neuropathy and oxidative stress
Pop‐Busui, R., Sima, A. A. F., & Stevens, M. J. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.625 · Cited by 286
Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway
Morales, A. I., Détaille, D., Prieto, M., Puente, A., Briones, E., Arévalo, M. A., Leverve, X. M., López-Novoa, J. M., & El‐Mir, M. (2010) · Kidney International · doi:10.1038/ki.2010.11 · Cited by 284
ZHANG, X., Dong, F., Ren, J. T., Driscoll, M., & Culver, B. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.10.011 · Cited by 290
Leydig cells: From stem cells to aging
Chen, H., Ge, R., & Zirkin, B. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.01.023 · Cited by 278
Pathophysiology of the Diabetic Kidney
Vallon, V., & Komers, R. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100049 · Cited by 291
Yano, M., Matsumura, T., Senokuchi, T., Ishii, N., Murata, Y., Taketa, K., Motoshima, H., Taguchi, T., Sonoda, K., Kukidome, D., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000268411.49545.9c · Cited by 236
Self-citationDiabetic nephropathy: Is there a role for oxidative stress?
Sagoo, M. K., & Gnudi, L. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.040 · Cited by 237
Bandeira, S. D. M., da Fonseca, L., Guedes, G. D. S., Rabelo, L. A., Goulart, M. O. F., & Vasconcelos, S. M. L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14023265 · Cited by 231
Activation of Nrf2 signaling by natural products-can it alleviate diabetes?
Matzinger, M., Fischhuber, K., & Heiß, E. H. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.015 · Cited by 208
Diabetic Nephropathy Is Associated with Oxidative Stress and Decreased Renal Nitric Oxide Production
Prabhakar, S. S., Starnes, J. D., Shi, S., Lonis, B., & Tran, R. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080895 · Cited by 202
Apostolova, N., Iannantuoni, F., Gruevska, A., Muntané, J., Rocha, M., & Víctor, V. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101517 · Cited by 208
Antioxidant Strategies in the Management of Diabetic Neuropathy
Oyenihi, A. B., Ayeleso, A. O., Mukwevho, E., & Masola, B. (2015) · BioMed Research International · doi:10.1155/2015/515042 · Cited by 192
Knockdown of Glyoxalase 1 Mimics Diabetic Nephropathy in Nondiabetic Mice
Giacco, F., Du, X., D’Agati, V. D., Milne, R. W., Sui, G., Geoffrion, M., & Brownlee, M. (2013) · Diabetes · doi:10.2337/db13-0316 · Cited by 184
Self-citationCheng, X., Siow, R. C. M., & Mann, G. E. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3283 · Cited by 182
Transcription factors in the pathogenesis of diabetic nephropathy
Sanchez, A. P., & Sharma, K. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001057 · Cited by 167
Hoffman, D. L., Salter, J. D., & Brookes, P. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00699.2006 · Cited by 165
Martínez‐Revelles, S., Avendaño, M. S., García‐Redondo, A. B., Álvarez, Y., Aguado, A., Pérez-Girón, J. V., García-Redondo, L., Esteban, V., Redondo, J. M., Alonso, M. J., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4335 · Cited by 159
Mitochondrial Dynamics and Mitochondrial Dysfunction in Diabetes.
Wada, J., & Nakatsuka, A. (2016) · PubMed · doi:10.18926/amo/54413 · Cited by 161
Inflammation in diabetic kidney disease
García-García, P. M. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.431 · Cited by 154
Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms
Tonna, S. J., El‐Osta, A., Cooper, M. E., & Tikellis, C. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.55 · Cited by 151
Isoe, T., Makino, Y., Mizumoto, K., Sakagami, H., Fujita, Y., Honjo, J., Takiyama, Y., Itoh, H., & Haneda, M. (2010) · Kidney International · doi:10.1038/ki.2010.99 · Cited by 152
Antioxidant and Anti-Inflammatory Effects of Exercise in Diabetic Patients
Golbidi, S., Badran, M., & Laher, I. (2011) · Experimental Diabetes Research · doi:10.1155/2012/941868 · Cited by 159
Montorfano, I., Becerra, Á., Cerro, R., Echeverría, C., Sáez, E., Morales, M. G., Fernández, R., Cabello‐Verrugio, C., & Simón, F. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.100 · Cited by 152
Redox Control of Renal Function and Hypertension
Nistala, R., Whaley‐Connell, A. T., & Sowers, J. R. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2034 · Cited by 147
Type 2 Diabetic Mice Have Increased Arteriolar Tone and Blood Pressure
Bagi, Z. A., Erdei, N., Tóth, A., Li, W., Hintze, T. H., Koller, Á., & Kaley, G. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000172688.26838.9f · Cited by 142
Vaziri, N. D., Bai, Y., Ni, Z., Quiroz, Y., Pandian, R., & Rodríguez‐Iturbe, B. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123638 · Cited by 145
Kellogg, A. P., Wiggin, T. D., Larkin, D. D., Hayes, J. M., Stevens, M. J., & Pop‐Busui, R. (2007) · Diabetes · doi:10.2337/db07-0740 · Cited by 140
Chu, S., Gu, J., Feng, L., Liu, J., Zhang, M., Jia, X., Liu, M., & Yao, D. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.01.018 · Cited by 140
Optimized multiplex immunofluorescence single-cell analysis reveals tuft cell heterogeneity
McKinley, E. T., Sui, Y., Al‐Kofahi, Y., Millis, B. A., Tyska, M. J., Roland, J. T., Santamaría-Pang, A., Ohland, C., Jobin, C., Franklin, J. L., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93487 · Cited by 135
Teixeira‐Lemos, E., de Oliveira, J. B. F., Pinheiro, J. P., & Reis, F. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/741545 · Cited by 136
Nox4 and diabetic nephropathy: With a friend like this, who needs enemies?
Gorin, Y. C., & Block, K. L. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.014 · Cited by 136
The Role of External and Matrix pH in Mitochondrial Reactive Oxygen Species Generation
Selivanov, V. A., Zeak, J. A., Roca, J., Cascante, M., Trucco, M., & Votyakova, T. V. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801019200 · Cited by 138
Impact of mitochondrial ROS production in the pathogenesis of insulin resistance
Nishikawa, T., Kukidome, D., Sonoda, K., Fujisawa, K., Matsuhisa, T., Motoshima, H., Matsumura, T., & Araki, E. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.071 · Cited by 132
Self-citationAstaxanthin protects mesangial cells from hyperglycemia‐induced oxidative signaling
Manabe, E., Handa, O., Naito, Y., Mizushima, K., Akagiri, S., Adachi, S., Takagi, T., Kokura, S., Maoka, T., & Yoshikawa, T. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21583 · Cited by 132
Waris, G., & Siddiqui, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9725-9734.2005 · Cited by 134
RetractedNRF2, cancer and calorie restriction
Martín‐Montalvo, A., Villalba, J. M., Navas, P., & de Cabo, R. (2010) · Oncogene · doi:10.1038/onc.2010.492 · Cited by 129
Hexokinase-2 Glycolytic Overload in Diabetes and Ischemia–Reperfusion Injury
Rabbani, N., & Thornalley, P. J. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.04.011 · Cited by 126
Kuhad, A., & Chopra, K. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.013 · Cited by 123
Nox as a target for diabetic complications
Gorin, Y. C., & Block, K. L. (2013) · Clinical Science · doi:10.1042/cs20130065 · Cited by 122
Szerafin, T., Erdei, N., Fülöp, T., Pásztor, E. T., Edes, I. F., Koller, Á., & Bagi, Z. A. (2006) · Circulation Research · doi:10.1161/01.res.0000241051.83067.62 · Cited by 120
Imoto, K., Kukidome, D., Nishikawa, T., Matsuhisa, T., Sonoda, K., Fujisawa, K., Yano, M., Motoshima, H., Taguchi, T., Tsuruzoe, K., et al. (2006) · Diabetes · doi:10.2337/db05-1187 · Cited by 117
Self-citationKaur, H., Chien, A., & Jialal, I. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00319.2012 · Cited by 115
Molecular Mechanisms of High Glucose-Induced Cyclooxygenase-2 Expression in Monocytes
Shanmugam, N., Gonzalo, I. T. G., & Natarajan, R. D. (2004) · Diabetes · doi:10.2337/diabetes.53.3.795 · Cited by 113
Amini, F. G., Rafieian‐Kopaei, M., Nematbakhsh, M., Baradaran, A., & Nasri, H. (2012) · Europe PMC (PubMed Central) · Cited by 111
Xu, Z., Lanting, L. L., Vaziri, N. D., Li, Z., Sepassi, L., Rodríguez‐Iturbe, B., & Natarajan, R. D. (2005) · Circulation · doi:10.1161/01.cir.0000161831.07637.63 · Cited by 110
Xia, L., Wang, H., Goldberg, H. J., Munk, S., Fantus, I. G., & Whiteside, C. I. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00119.2005 · Cited by 109
Mitophagy and mitochondrial dynamics in type 2 diabetes mellitus treatment
Shan, Z., Fa, W. H., Tian, C. R., Yuan, C. S., & Ning, J. (2022) · Aging · doi:10.18632/aging.203969 · Cited by 107
Alaofi, A. L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01119 · Cited by 109
Wuensch, T., Thilo, F., Krueger, K., Scholze, A., Ristow, M., & Tepel, M. (2010) · Diabetes · doi:10.2337/db09-1100 · Cited by 103
High Perfusion Pressure Accelerates Renal Injury in Salt-Sensitive Hypertension
Mori, T., Polichnowski, A. J., Glocka, P., Kaldunski, M. L., Ohsaki, Y., Liang, M., & Cowley, A. W. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121271 · Cited by 99
Hernanz, R., Briones, A. M., Salaíces, M., & Alonso, M. J. (2013) · Clinical Science · doi:10.1042/cs20120651 · Cited by 100
Thallas‐Bonke, V., Jha, J. C., Gray, S. P., Barit, D., Haller, H. G., Schmidt, H. H. H. W., Coughlan, M. T., Cooper, M. E., Forbes, J. M., & Jandeleit-Dahm, K. A. M. (2014) · Physiological Reports · doi:10.14814/phy2.12192 · Cited by 102
Molecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future?
Pusparajah, P., Lee, L., & Kadir, K. A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00200 · Cited by 99
Lin, C., Wang, F.-S., Kuo, Y., Huang, Y., Huang, H.-T., Sun, Y., & Kuo, Y.-T. (2006) · Kidney International · doi:10.1038/sj.ki.5000329 · Cited by 99
Cardiovascular complications of non-steroidal anti-inflammatory drugs.
Fosslien, E. (2005) · PubMed · Cited by 99
Impact of mitochondrial ROS production on diabetic vascular complications
Nishikawa, T., Kukidome, D., Sonoda, K., Fujisawa, K., Matsuhisa, T., Motoshima, H., Matsumura, T., & Araki, E. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.031 · Cited by 98
Self-citationGuo, K., Lu, J., Huang, Y., Wu, M., Zhang, L., Yu, H., Zhang, M., Bao, Y., He, C., Chen, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125176 · Cited by 98
Guo, Z., Xia, Z., Jiang, J., & McNeill, J. H. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01328.2005 · Cited by 98
Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy
Lindblom, R. S. J., Higgins, G. C., Coughlan, M. T., & de Haan, J. B. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.134 · Cited by 99
TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis
Fujisawa, K., Nishikawa, T., Kukidome, D., Imoto, K., Yamashiro, T., Motoshima, H., Matsumura, T., & Araki, E. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.141 · Cited by 97
Self-citationLycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain
Kuhad, A., Sharma, S., & Chopra, K. (2007) · European Journal of Pain · doi:10.1016/j.ejpain.2007.10.008 · Cited by 92
Raish, M., Ahmad, A., Jan, B. L., Alkharfy, K. M., Ansari, M. A., Kazi, M., Al-Jenoobi, F. I., & Al-Mohizea, A. M. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.05.090 · Cited by 92
Dougherty, C. J., Kubasiak, L. A., Frazier, D. P., Li, H., Xiong, W., Bishopric, N. H., & Webster, K. A. (2004) · The FASEB Journal · doi:10.1096/fj.04-1505com · Cited by 93
Nasri, H., Nematbakhsh, M., Ghobadi, S., Ansari, R., Shahinfard, N., & Rafieian‐Kopaei, M. (2013) · Europe PMC (PubMed Central) · Cited by 90
Seo, K., Yang, J. H., Kim, S. C., Ku, S. K., Ki, S. H., & Shin, S. M. (2014) · Inflammation · doi:10.1007/s10753-013-9789-6 · Cited by 90
Reactive Oxygen Species: Not Omnipresent but Important in Many Locations
Herb, M., Gluschko, A., & Schramm, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716406 · Cited by 93
The Dualistic Effect of COX-2-Mediated Signaling in Obesity and Insulin Resistance
Chan, P., Liao, M.-T., & Hsieh, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133115 · Cited by 85
Diabetic nephropathy: a disorder of oxygen metabolism?
Miyata, T., & de Strihou, C. V. Y. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.211 · Cited by 82
Coronary microvascular dysfunction in diabetes mellitus: A review
Picchi, A. (2010) · World Journal of Cardiology · doi:10.4330/wjc.v2.i11.377 · Cited by 84
Ochiai, Y., Kaburagi, S., Obayashi, K., Ujiie, N., Hashimoto, S., Okano, Y., Masaki, H., Ichihashi, M., & Sakurai, H. (2006) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2006.07.001 · Cited by 83
Chandramohan, G., Bai, Y., Norris, K. C., Rodríguez‐Iturbe, B., & Vaziri, N. D. (2007) · American Journal of Nephrology · doi:10.1159/000110021 · Cited by 84
Metadata
- Authors
- Kiritoshi, S., Nishikawa, T., Sonoda, K., Kukidome, D., Senokuchi, T., Matsuo, T., Matsumura, T., Tokunaga, H., Brownlee, M., & Araki, E.
- Affiliations
- Kumamoto University (JP)
- Albert Einstein College of Medicine (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2003-10-01
- Volume
- 52
- Issue
- 10
- Pages
- 2570-2577
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2468150319
- Cited by
- 345
- References
- 31
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 7 · 2023: 8 · 2022: 18 · 2021: 12 · 2020: 8 · 2019: 12 · 2018: 10 · 2017: 11 · 2016: 15 · 2015: 14 · 2014: 20 · 2013: 16 · 2012: 26
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Kanae Foundation for the Promotion of Medical Science
- Japan Diabetes Foundation
- Japan Society for the Promotion of Science (14571100)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- reactive oxygen species, mitochondrial reactive oxygen species, cyclooxygenase-2, mesangial cells, hyperglycemia, NF-κB, prostaglandin E2, diabetic nephropathy, glomerular hyperfiltration, UCP1, manganese superoxide dismutase, COX-2 promoter, streptozotocin-induced diabetes
- MeSH terms
- Uncoupling Protein 1, Animals, Carbonyl Cyanide m-Chlorophenyl Hydrazone, Carrier Proteins, Cells, Cultured, Chelating Agents, Diabetes Mellitus, Experimental, Diabetic Neuropathies, Dose-Response Relationship, Drug, Glomerular Mesangium, Glucose, Humans, Ion Channels, Ionophores, Isoenzymes, Membrane Proteins, Mitochondria, Promoter Regions, Genetic, Prostaglandin-Endoperoxide Synthases, RNA, Messenger, Superoxide Dismutase, Thenoyltrifluoroacetone, Gene Expression, Reactive Oxygen Species, Mitochondrial Proteins, Mice, Cyclooxygenase 1, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review